EGFR and non-small cell lung carcinoma: These studies confirmed that cerebral radiotherapy improves the effectiveness of EGFR-TKI therapy by disrupting the blood–brain barrier (BBB), especially for NSCLC patients with NSCLC with BM and EGFR mutations.